Clinical trial
A Phase 1a/1b Basket Trial of BMS-986504 With Standard-of-Care Therapy For Patients With Select Metastatic MTAP-deleted Solid Tumors
NCT07532902 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1a/1b Basket Trial of BMS-986504 With Standard-of-Care Therapy For Patients With Select Metastatic MTAP-deleted Solid Tumors
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 7, 2026
- Completion date
- April 30, 2029
- Enrollment
- 60 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
diffuse pleural mesothelioma, gastroesophageal carcinoma, urothelial carcinoma